Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams

EP: 1.PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

EP: 2.Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care

EP: 3.The Role of PSMA PET in Early Detection and Prostate Cancer Staging

EP: 4.Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

EP: 5.Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice

EP: 6.Evaluating Imaging Agents in Oligometastatic Prostate Cancer: A Comparative Analysis of Gallium-Based and Non-Gallium-Based Options

EP: 7.Optimal Timing and Frequency of Imagining Agents Used in the Detection and Characterization of Oligometastatic Prostate Cancer

Now Viewing

EP: 8.Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams

EP: 9.Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability

EP: 10.Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging

Video content above is prompted by the following:

• How does PSMA PET imaging fit into the multidisciplinary approach to prostate cancer management, and what benefits and challenges arise when collaborating with other specialists to use its results for patient care?
• Have you observed any differences in the availability or accessibility of PSMA PET imaging based on geographical location or healthcare facility type?